Assessment of the efficacy and safety of anti-sclerostin antibody therapy for osteoporosis in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials

Authors

Institutions

Publication Details

Journal
Frontiers in Endocrinology
Published
2026-01-19
DOI
https://doi.org/10.3389/fendo.2025.1732708
Primary Topic
Bone health and osteoporosis research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Assessment of the efficacy and safety of anti-sclerostin antibody therapy for osteoporosis in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials

Lianzhi Chen, Mingxi Gu, Qingwen Wang
Frontiers in Endocrinology
Bone health and osteoporosis research
article

Assessment of the efficacy and safety of anti-sclerostin antibody therapy for osteoporosis in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials

Lianzhi Chen, Mingxi Gu, Qingwen Wang
article en

Abstract

No abstract available for this paper.
Frontiers in EndocrinologyVol. 16
Shenzhen Center for Disease Control and Prevention (CN), Peking University Shenzhen Hospital (CN)
Sanming Project of Medicine in Shenzhen, Basic and Applied Basic Research Foundation of Guangdong Province
Good health and well-being
Openalex Percentile: Top 85%
Bone health and osteoporosis research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.